Stocklytics Platform
Asset logo for symbol AXNX
Axonics Modulation Technologies
AXNX64
$70.98arrow_drop_up0.75%$0.53
Asset logo for symbol AXNX
AXNX64

$70.98

arrow_drop_up0.75%
Key Stats
Open$70.50
Prev. Close$70.45
EPS-0.10
DividendNon-Dividend
Next Earnings Date-
Dividend Yield %-
PE Ratio-
LOWHIGH
Day Range70.30
71.01
52 Week Range48.30
71.01
Ratios
EPS-0.10
Fundamentals
Payout Ratio-
Industry average yield2.87%
Last Dividend pay date-
Dividend per share-
Dividend yield forecast-

Stock Analysis

Technicals

Summarizing what the indicators are suggesting.

Strong Buy
Buy
Neutral
Sell
Strong Sell

Analyst rating

An aggregate view of professional's ratings.

Strong Buy
Buy
Neutral
Sell
Strong Sell

Stock Performance

AXNX-
US Healthcare Sector-
US Market-
warning

AXNX / Market

AXNX lose to the US Market which returned 1.31% over the last twenty four hours.
warning

AXNX / Healthcare Sector

AXNX lose to the US Healthcare sector which returned 2.66% over the last twenty four hours.

Axonics Modulation Technologies (AXNX) Statistics

Axonics Modulation Technologies Inc (AXNX) is a medical technology company that specializes in the development and commercialization of innovative solutions for the treatment of various bladder and bowel dysfunction disorders. The company's primary product is the Axonics System, which is a miniaturized implantable neurostimulator that helps in the modulation of nerves that control the bladder and bowel functions. The Axonics System offers significant advantages over traditional sacral neuromodulation devices, including a longer battery life and a smaller size, which enhances patient comfort and convenience.
The stock statistics of Axonics Modulation Technologies Inc (AXNX) provide valuable insights into its performance and market trends. As of the latest available data, the stock has a market capitalization of $4.56 billion. The current share price is $88.46, with a 52-week high of $143.25 and a 52-week low of $26.10. The stock has shown strong performance, with a year-to-date return of 38.21%. The average trading volume is approximately 501,000 shares per day. These statistics indicate a positive market sentiment and investor confidence in the company's future prospects.
add Axonics Modulation Technologies  to watchlist

Keep an eye on Axonics Modulation Technologies

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

search
help

How has Axonics Modulation Technologies (AXNX) stock's performance compared to its sector and the market over the past year?

Over the past year, Axonics Modulation Technologies (AXNX) has experienced a price change of . Compared to the Healthcare sector, which saw a change of 27.09%, Axonics Modulation Technologies has underperformed compared to its sector, indicating its relative standing within the Healthcare sector. Against the broader market's change of 48.15%, it has fallen short of the market average. This comparison highlights Axonics Modulation Technologies 's performance relative to both its sector and the overall market over the last year.
help

What is the PE ratio of Axonics Modulation Technologies (AXNX) stock?

The PE ratio for Axonics Modulation Technologies (AXNX) is currently not available. This could be due to a variety of factors such as the company not having positive earnings at the moment or recent updates not being reflected.
help

What is the EPS of Axonics Modulation Technologies (AXNX) stock?

The Earnings Per Share (EPS) for Axonics Modulation Technologies (AXNX), calculated on a diluted basis, is -$0.1. EPS is a key indicator of a company's profitability, showing the portion of a company's profit allocated to each outstanding share of common stock.
help

What is the operating margin of Axonics Modulation Technologies (AXNX) stock?

The operating margin for Axonics Modulation Technologies (AXNX) is -2.41%. This metric represents the percentage of revenue that remains after paying for variable production costs, indicating the efficiency and profitability of the company's core business operations.
help

What is the EBITDA of Axonics Modulation Technologies (AXNX) stock?

The EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) of Axonics Modulation Technologies (AXNX) is -$102.52M. EBITDA is a widely used earnings metric to assess a company's operational efficiency and profitability before the impact of non-operating decisions such as financing, accounting, and tax environments.
help

How much debt does Axonics Modulation Technologies (AXNX) have?

Axonics Modulation Technologies (AXNX) has a total debt of $49.82M. The net debt, which accounts for cash and cash equivalents against the total debt, is -$206.94M.

Take Your Investments to a Whole New Level